glp 1 agonists vs sglt2 inhibitors GLP-1 Receptor Agonist Therapy With and Without in Patients With Type 2 Diabetes SGLT2 vs GLP-1 for CKD:
Description
Not even close
Zhu C, Lai Y, Liu C, Teng L, Zhu Y, Lin X, et al
Use of any of these antihyperglycemic medications is not without risk, however, and the choice to use any of these agents in a patient should consider both potential risks and benefits of therapy
Incretin hormones: revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity
